CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 272 enrolled
Drug / intervention
Lorcaserin +1 moredrug
Likely dose
Placebo Oral Capsule 10mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03007394
NCT03007394Phase 2Completed
CompareCT.gov

Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder

National Institute on Drug Abuse (NIDA)·interventional·Posted Jan 2, 2017·Updated Aug 5, 2020

In Brief

A Phase 2 clinical trial evaluating Lorcaserin and Placebo Oral Capsule for Cocaine-Related Disorders. Completed, enrolled 272 participants across 12 sites.

Detailed Summary

The objective of this study is to evaluate the efficacy and safety of lorcaserin in the treatment of cocaine use disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCocaine-Related Disorders
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedJan 2, 2017
Enrollment StartDec 19, 2017
Primary CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 9.5 years ago

Interventions

Lorcaserindrug

Lorcaserin Capsule

Placebo Oral Capsuledrug

sugar pill to mimic lorcaserin 10mg capsule